 |
Bicara Therapeutics
Last updated: August 01, 2025
CEO - Claire Mazumdar
USA | Funding: $313M (+)
Website: https://www.bicara.com
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Website: https://www.bicara.com
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
